Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders.

[1]  E. Schiff,et al.  Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. , 2013, The New England journal of medicine.

[2]  John McNally,et al.  Sofosbuvir for previously untreated chronic hepatitis C infection. , 2013, The New England journal of medicine.

[3]  T. Asselah,et al.  Interferon free therapy with direct acting antivirals for HCV , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[4]  T. Pilot‐Matias,et al.  Exploratory study of oral combination antiviral therapy for hepatitis C. , 2013, The New England journal of medicine.

[5]  F. Zoulim,et al.  New approaches to the management of hepatitis C in haemophilia in 2012 , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  K. Ghosh,et al.  Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers: a rebuttal , 2012, Journal of thrombosis and haemostasis : JTH.

[7]  A. Craxì,et al.  2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[8]  Anna Persson,et al.  Preliminary study of two antiviral agents for hepatitis C genotype 1. , 2012, The New England journal of medicine.

[9]  M. Morfini,et al.  Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers , 2012, Journal of thrombosis and haemostasis : JTH.

[10]  V. Jiménez‐Yuste,et al.  Liver transplantation in Spanish haemophiliacs , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  M. Sherman,et al.  Criteria for liver transplantation for HCC: what should the limits be? , 2011, Journal of hepatology.

[12]  K. V. van Erpecum,et al.  Impact of Fibroscan on management of chronic viral hepatitis in clinical practice. , 2011, Annals of hepatology.

[13]  M. Makuuchi,et al.  Living Donor Liver Transplantations in HIV- and Hepatitis C Virus-Coinfected Hemophiliacs: Experience in a Single Center , 2011, Transplantation.

[14]  Sprint Investigators,et al.  Boceprevir for Untreated Chronic HCV Genotype 1 Infection , 2011 .

[15]  A. Street,et al.  The prevalence of significant liver fibrosis and cirrhosis in haemophilia patients infected with hepatitis C using FibroScan , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  J. Li,et al.  Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  M. Manns,et al.  Telaprevir for previously treated chronic HCV infection. , 2010, The New England journal of medicine.

[18]  M. Krahn,et al.  Prognosis of hepatitis C virus‐infected Canadian post‐transfusion compensation claimant cohort , 2009, Journal of viral hepatitis.

[19]  E. Tsochatzis,et al.  Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B , 2009, Scandinavian journal of gastroenterology.

[20]  N. Enomoto,et al.  The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy. , 2008, Journal of hepatology.

[21]  M. Makris,et al.  Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study , 2007, Journal of thrombosis and haemostasis : JTH.

[22]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[23]  K. V. van Erpecum,et al.  Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. , 2007, Blood.

[24]  T. Liang,et al.  Hepatitis C — identifying patients with progressive liver injury , 2006, Hepatology.

[25]  J. Goedert,et al.  Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. , 2005, Blood.

[26]  T. Asselah,et al.  Long-term outcome of hepatitis C infection after bone marrow transplantation. , 2004, Blood.

[27]  J. Wilde,et al.  HIV and HCV coinfection in haemophilia , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[28]  G. Norkrans,et al.  Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. , 2002, Journal of hepatology.

[29]  T. Asselah,et al.  Fibrosis and disease progression in hepatitis C , 2002, Hepatology.

[30]  L. Seeff,et al.  Natural history of chronic hepatitis C , 2002, Hepatology.

[31]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[32]  J. Goedert,et al.  End-stage liver disease in persons with hemophilia and transfusion-associated infections. , 2002, Blood.

[33]  B. Gunson,et al.  Liver transplantation in haemophilia , 2002, British journal of haematology.

[34]  Kenneth Koury,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[35]  G. Lippi,et al.  The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. , 2001, Blood.

[36]  S. Belle,et al.  Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. , 2001, The Journal of infectious diseases.

[37]  C. Sabin,et al.  The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985 , 2000, Gut.

[38]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[39]  F. Preston,et al.  Reduced risk of non‐A, non‐B hepatitis after a first exposure to ‘wet heated’factor VIII concentrate , 1987, British journal of haematology.

[40]  M. Manns,et al.  Boceprevir for untreated chronic HCV genotype 1 infection. , 2011, The New England journal of medicine.

[41]  William M. Lee,et al.  Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. , 2009, Gastroenterology.

[42]  E. Santagostino,et al.  High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C. , 2006, Haematologica.

[43]  E. Santagostino,et al.  The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study. , 2006, Haematologica.

[44]  V. Soriano,et al.  [HIV and HCV coinfection]. , 2006, Enfermedades infecciosas y microbiologia clinica.

[45]  D. Thabut,et al.  Natural history and predictors of disease severity in chronic hepatitis C. , 2006, Journal of hepatology.